Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 23Terminated 10Recruiting 9Active not recruiting 7Suspended 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Testicular Neoplasms 1Hypogonadism 1Brain Neoplasms 1

Interventions

Specimen Handling 12Magnetic Resonance Spectroscopy 10Cyclophosphamide 10Cisplatin 7Bevacizumab 7pembrolizumab 6Radiosurgery 6Oxaliplatin 5Nivolumab 5Irinotecan 5Fluorouracil 5Everolimus 5Capecitabine 5Biopsy 5venetoclax 4fludarabine 4S 1 (combination) 4Prednisone 4Leucovorin 4Gemcitabine 4Etoposide 4Drug Therapy 4Doxorubicin 4Azacitidine 4fludarabine phosphate 3Vincristine 3Taxes 3Tacrolimus 3Surveys and Questionnaires 3Surgical Procedures, Operative 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × OTHER × Mental Status and Dementia Tests × Clear all
NCT06191575 2026-06-05

7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy

University of Southern California

Suspended
10 enrolled
Genitourinary

Hypogonadism, Testicular Neoplasms

NCT05428852 2026-02-10

Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
24 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡